ODAC Rejects Temodal for Melanoma After Discussion Of Approval Standards
In Brief: Fidler Wins BMS Cancer Research Award; Thomas Cech To Head Howard Hughs Inst.
Capitol Hill: Bills Seeks Coverage for Treatment Of cancers Found in CDC Screening
Clinical trials: ORI Cites Data Manager For Misconduct; Results Not Affects, NCI Says
Science Policy: NI DOD Begins Project For Common Coding Of Cancer Grants
In Brief: Ahoy! It’s “Admiral Rick”
Professional Societies: AACR Awards Honor 8 Scientists, Clinicians
Trending Stories
- Trump backs off the 100% pharma tariffs ultimatum
- ASCO and Google Cloud set forth a vision for using AI to modernize health care and advance oncology
- KRAS pioneer and Stephenson Prize winner Frank McCormick aims to prevent all KRAS cancers with a pill
- White House announces “TrumpRx,” a new prescription drug website
- Pulitzer-winning healthcare reporter Laurie McGinley on her shift to advocacy work with PACR
- The Directors: Steven Artandi and Eric Winer on how looming policy changes “reverberate” through oncology
“Even when funding gets restored and if the H-1B visa threat doesn’t materialize, it creates an environment where especially young people become uncertain.”